|
LOC374443 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.624600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.267000E-01 |
| Normal-vs-Stage2 |
8.382400E-04 |
| Normal-vs-Stage3 |
9.994000E-01 |
| Normal-vs-Stage4 |
8.534800E-01 |
| Stage1-vs-Stage2 |
6.79160000016665E-07 |
| Stage1-vs-Stage3 |
8.746000E-01 |
| Stage1-vs-Stage4 |
7.201600E-01 |
| Stage2-vs-Stage3 |
2.74270000000243E-06 |
| Stage2-vs-Stage4 |
1.769900E-04 |
| Stage3-vs-Stage4 |
7.954400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.356200E-01 |
| Normal-vs-AfricanAmerican |
9.505400E-01 |
| Normal-vs-Asian |
3.936600E-01 |
| Caucasian-vs-AfricanAmerican |
7.805800E-01 |
| Caucasian-vs-Asian |
8.452500E-02 |
| AfricanAmerican-vs-Asian |
4.549000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.057600E-01 |
| Normal-vs-Female |
6.873600E-01 |
| Male-vs-Female |
8.336200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.914200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.431200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.717400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.299400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.489190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.951900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.061400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.062600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.895800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.368620E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.901800E-03 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
2.997400E-01 |
| Classical-VS-Normal |
5.998000E-01 |
| Tall-VS-Follicular |
1.12799991569545E-10 |
| Tall-VS-Other |
2.116400E-02 |
| Tall-VS-Normal |
2.165800E-02 |
| Follicular-VS-Other |
8.362700E-03 |
| Follicular-VS-Normal |
2.0607999999922E-05 |
| Other-VS-Normal |
4.119800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.031020E-01 |
| Normal-vs-N1 |
6.645800E-01 |
| N0-vs-N1 |
4.162500E-03 |
|
|
